- 0
February 2013Kibooco CEO Molly Schneeberg described Mitacs as a “matchmaker” that provides small businesses like hers access to matching funds, knowledge and networks that aren’t otherwise within reach. - 0
January 2013Olga’s Mitacs Elevate project is focused on the analysis of survivin, a protein that is involved in critical pathways of cancer cell growth and survival. - 0
January 2013The system created... gives CTS a major competitive advantage, reduces their infrastructure costs tremendously and saves them from having to hire countless employees in global locations. - 0
December 2012My experiences with Mitacs-Accelerate have set me apart from my PhD student peers, as I now feel more comfortable in an industry environment – and even prefer it over an academic one. - 0
December 2012The Mitacs-Accelerate program gives students the best of both worlds when it comes to academia and industry-driven research and development. - 0
November 2012Rafael Falcon had no idea that winning a poster competition organized by the Faculty of Engineering of the University of Ottawa would generate the attention needed to land his dream job. - 0
October 2012Mitacs-Accelerate is allowing our company to create an off-the-shelf and user-friendly tool that will allow artists to add 3D layers to their work in spatial drawing applications. We hope that it eventually become an industry-standard stereoscopic 3D animation tool. - 0
September 2012Side Effects Software turned to Yeleiny Bonilla through Mitacs Accelerate for web performance expertise. - 0
August 2012With the help of Mitacs Accelerate intern, Talia Webber, Orpyx is performing research to evaluate the device’s ability to accurately measure foot pressures, an important step in the development and commercialization of the product. - 0
August 2011The collaboration also gave Zaifman a window into the way industry operates. “It was a real eye-opener to see how a company operates. It is very different from the academic experience, it was a new experience for me. Things like communications, project goals, and deadlines are approached very differently in an industry setting.” - 0
May 2011One of the most talked-about biomedical breakthroughs of 2010, this new development offers hope to sufferers of blood and immunological diseases, such as leukemias, who are often unable to find a suitable donor.
Join a thriving innovation ecosystem. Subscribe now
© Copyright 2023, Mitacs. All rights reserved. Privacy Statement